The stock of Atricure Inc (ATRC) has seen a 7.42% increase in the past week, with a -9.00% drop in the past month, and a -27.30% decrease in the past quarter. The volatility ratio for the week is 5.21%, and the volatility levels for the past 30 days are at 4.42% for ATRC. The simple moving average for the last 20 days is 1.77% for ATRC’s stock, with a simple moving average of -34.42% for the last 200 days.
Is It Worth Investing in Atricure Inc (NASDAQ: ATRC) Right Now?
Moreover, the 36-month beta value for ATRC is 1.41. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 3 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for ATRC is 46.84M and currently, short sellers hold a 6.83% of that float. On May 02, 2024, ATRC’s average trading volume was 732.02K shares.
ATRC) stock’s latest price update
The stock of Atricure Inc (NASDAQ: ATRC) has increased by 2.65 when compared to last closing price of 24.12.Despite this, the company has seen a gain of 7.42% in its stock price over the last five trading days. Zacks Investment Research reported 2024-05-01 that The headline numbers for AtriCure (ATRC) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Analysts’ Opinion of ATRC
Many brokerage firms have already submitted their reports for ATRC stocks, with Oppenheimer repeating the rating for ATRC by listing it as a “Outperform.” The predicted price for ATRC in the upcoming period, according to Oppenheimer is $32 based on the research report published on April 23, 2024 of the current year 2024.
JMP Securities, on the other hand, stated in their research note that they expect to see ATRC reach a price target of $60. The rating they have provided for ATRC stocks is “Mkt Outperform” according to the report published on October 23rd, 2023.
UBS gave a rating of “Buy” to ATRC, setting the target price at $56 in the report published on September 29th of the previous year.
ATRC Trading at -16.12% from the 50-Day Moving Average
After a stumble in the market that brought ATRC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -58.46% of loss for the given period.
Volatility was left at 4.42%, however, over the last 30 days, the volatility rate increased by 5.21%, as shares sank -6.50% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -24.99% lower at present.
During the last 5 trading sessions, ATRC rose by +7.42%, which changed the moving average for the period of 200-days by -53.55% in comparison to the 20-day moving average, which settled at $24.24. In addition, Atricure Inc saw -30.62% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ATRC starting from Noznesky Justin J, who sale 1,500 shares at the price of $30.39 back on Apr 01 ’24. After this action, Noznesky Justin J now owns 72,784 shares of Atricure Inc, valued at $45,585 using the latest closing price.
Dahlquist Karl S., the Chief Legal Officer of Atricure Inc, sale 1,885 shares at $32.16 during a trade that took place back on Mar 18 ’24, which means that Dahlquist Karl S. is holding 50,954 shares at $60,622 based on the most recent closing price.
Stock Fundamentals for ATRC
Current profitability levels for the company are sitting at:
- -0.07 for the present operating margin
- 0.75 for the gross margin
The net margin for Atricure Inc stands at -0.08. The total capital return value is set at -0.05. Equity return is now at value -6.60, with -5.08 for asset returns.
Based on Atricure Inc (ATRC), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at 0.07. The debt to equity ratio resting at 0.14. The interest coverage ratio of the stock is 8.02.
Currently, EBITDA for the company is -16.28 million with net debt to EBITDA at 0.44. When we switch over and look at the enterprise to sales, we see a ratio of 2.98. The receivables turnover for the company is 7.6for trailing twelve months and the total asset turnover is 0.65. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.57.
Conclusion
To wrap up, the performance of Atricure Inc (ATRC) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
